Sponsors
For information on Sponsor opportunities, please contact the Sponsorship Department SponsorEKS@oic.it.
EKS 2025 has received a COMPLIANT assessment by Ethical MedTech Europe (EMT-25-03900).
MedTech Europe Code of Ethical Business Practice regulates all aspects of the industry’s relationship with Healthcare Professionals (HCPs) and Healthcare Organisations (HCOs) such as: company organised events, arrangements with consultants, research and financial support to medical education, amongst others. It also introduces an independent enforcement mechanism.
From 1 January 2018, MedTech Europe Member Companies and their representatives no longer permit to provide direct financial support to individual HCPs from the MedTech Europe Geographic area, which includes EU and EEA countries as well as Russia, Turkey and the countries governed by Mecomed to attend Third-Party Organised Events.
Support to medical education offered to Third Party Organised Events must be provided through Educational Grants given to HCOs, such as scientific societies, hospitals or foundations or Professional Congress Organisers (PCOs). The selection of the beneficiaries of these Grants must be the sole responsibility of the HCO/PCO receiving the Educational Grant.
Companies that are interested in granting an Educational Support for EKS 2025 are welcome to contact sponsorEKS@oic.it.
DIAMOND
Orthopaedic solutions from Johnson & Johnson MedTech
Across Johnson & Johnson, we are tackling the world’s most complex and pervasive health challenges.
In Orthopaedics, we are on a mission to keep people moving by leveraging our deep expertise in joint reconstruction, robotics and enabling tech, spine, sports, trauma, and extremities, to develop the next generation of medtech solutions. We offer one of the most comprehensive Orthopaedics portfolios in the world that helps heal and restore movement for the millions of patients we serve.
For more, visit https://www.jnjmedtech.com/en-EMEA/companies/depuy-synthes
Orthopaedics
Orthopaedics includes an innovative range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and Trauma products used to stabilise severe fractures and correct bone deformities.
Our Hip and Knee Implant portfolio includes products made from OXINIUM, an advanced load bearing technology created through a proprietary manufacturing process. We believe that OXINIUM exhibits unique performance characteristics due to its hardness, low-friction and resistance to roughening and abrasion.
For more information about Enovis, please visit our website.
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.
For more information about our product portfolio visit www.zimmerbiomet.eu or follow us on LinkedIn www.linkedin.com/company/zimmer-biomet-emea/
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes.
Today, we are one of the world’s leading medical technology companies, and alongside our customers, we are impacting the lives of millions of patients each year. Our diverse array of innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine help improve patient and healthcare outcomes. As our portfolio grows, our culture still reflects Dr. Stryker’s legacy, and we are well-positioned to continue making healthcare better for generations to come.
Visit www.striker.com.
TITANIUM
We’re Enovis – a global medical technology innovator dedicated to improving lives by developing clinically differentiated solutions that enhance patient outcomes and restore motion for life.
We strive to make each day better by partnering with the brightest minds in health to advance care that is smarter, personalized, and more effective, while improving operational efficiency for surgeons and clinicians around the world. We do this through our extraordinary talent, a relentless focus on innovation, strategic acquisitions, and a common culture of continuous improvement.
With more than 7,000 extraordinary employees worldwide and an extensive range of products, services, and integrated technologies our solutions impact the well-being of millions of patients wherever they are on their pathway to health.
For more information about Enovis, please visit enovis.com.
EXHIBITORS
implantcast GmbH is a leading German medical technology company specializing in the development, production, and distribution of innovative endoprosthetic solutions. Founded in 1988 and headquartered in Buxtehude, Germany, implantcast has grown into a globally recognized provider of high-quality joint replacement systems and custom-made implants for complex orthopedic cases.
With a strong foundation in research and development, implantcast is committed to advancing medical care through precision-engineered prosthetics that meet the highest standards of safety, performance, and patient-specific adaptability. The company offers a comprehensive portfolio that includes hip, knee, shoulder, and tumor prostheses, along with individual custom implants and revision systems tailored to complex surgical needs.
implantcast maintains a strong customer focus, emphasizing close collaboration with surgeons and healthcare professionals to ensure optimal clinical outcomes. The company operates with a clear set of values centered around innovation, quality, integrity, and responsibility—both to patients and to the medical community.
With a dedicated team of over 800 employees and a presence in more than 80 countries, implantcast continues to set benchmarks in endoprosthetics. Its commitment to sustainable growth, continuous innovation, and excellence in service drives the company’s goal of improving mobility and quality of life for patients worldwide.
Visit our website www.implantcast.de.
Medacta is a global key player specializing in the design, production, and distribution of innovative, personalized, and sustainable solutions for joint replacement, sports medicine, and spine surgery. Established in 1999 in Switzerland, Medacta is committed to improving the care and well-being of patients and maintains a strong focus on healthcare sustainability. Through close collaboration with expert surgeons globally, continuous investments in R&D, and the adoption of cutting-edge technologies, Medacta’s innovation prioritizes minimally invasive surgery and personalized solutions for every patient. Through the M.O.R.E. Institute, Medacta supports surgeons with a comprehensive and tailored program dedicated to the advancement of medical education. Medacta is headquartered in Castel San Pietro, Switzerland, and operates in over 60 countries.
Visit our website www.medacta.com.
Symbios is a Swiss medical technology company, and the leader in individualized orthopedic implants for hip and knee joint replacement.
It was founded in 1989 by Jean Plé and two associates, including an orthopedic surgeon. Their vision was to design and manufacture individualized implants that adapt perfectly to each patient’s individual anatomy.
As there are as many different body shapes as there are patients, an individualized implant is above all a unique implant for a unique patient, designed to better restore mobility and satisfaction.
Since its creation and based today on 30 years of experience, Symbios has pioneered and constantly improved the technology of individualized implant manufacturing, thus becoming the company with the greatest expertise in this field worldwide.
In addition to providing products that are better adapted to patients, customization of implants enables a major breakthrough in today’s orthopedic supply model, allowing for a significant reduction in stocks and instruments for healthcare facilities. The cost of healthcare linked to changing demographics is a growing concern, and we believe that this is the ultimate way to maximize the efficiency of healthcare facilities and enable them to reduce operational costs in the future, while improving the quality of care.
Visit our website https://symbios.ch.